Cargando…
Neuroprotective Therapy in Parkinson's Disease: Current Status and New Directions from Experimental and Genetic Clues
Despite successful treatment of Parkinson's disease (PD) with a wide variety of symptomatic therapy, the disease continues to progress and drug-resistance symptoms become the predominant factors producing the disability of PD patients. Neuroprotective therapies have been tested, but clinically...
Autores principales: | Lin, William, Kang, Un Jung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854916/ https://www.ncbi.nlm.nih.gov/pubmed/20396458 http://dx.doi.org/10.3988/jcn.2005.1.2.107 |
Ejemplares similares
-
Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies
por: Ebanks, Kirsten, et al.
Publicado: (2020) -
The current status of gene therapy for Parkinson's disease
por: Muramatsu, Shin-ichi
Publicado: (2010) -
Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
por: Lee, Joo-Eun, et al.
Publicado: (2020) -
Dermatological Manifestations of Parkinson's Disease: Clues for Diagnosis
por: Shahid, Wajeeha, et al.
Publicado: (2020) -
Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
por: Pachman, Lauren M., et al.
Publicado: (2021)